CNCR vs. FPXE ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to First Trust IPOX Europe Equity Opportunities ETF (FPXE)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$14.86
Average Daily Volume
41,471
71
FPXE
First Trust IPOX Europe Equity Opportunities ETF
FPXE Description
The First Trust IPOX® Europe Equity Opportunities ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the IPOX® 100 Europe Index (the "Index"). The Fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks and/or depositary receipts that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Fund's investment advisor seeks a correlation of 0.95 or better (before fees and expenses) between the Fund's performance and the performance of the Index; a figure of 1.00 would represent perfect correlation. The Index is owned, developed, maintained and sponsored by IPOX® Schuster LLC (the "Index Provider").Grade (RS Rating)
Last Trade
$25.15
Average Daily Volume
233
23
Performance
| Period | CNCR | FPXE |
|---|---|---|
| 30 Days | -4.44% | 1.41% |
| 60 Days | -10.96% | 1.73% |
| 90 Days | -4.25% | 6.59% |
| 12 Months | 10.90% | 18.45% |
CNCR Overweight 68 Positions Relative to FPXE
| Symbol | Grade | Weight | |
|---|---|---|---|
| GERN | C | 3.05% | |
| CGEM | C | 2.17% | |
| ACRV | C | 2.12% | |
| DCPH | A | 2.08% | |
| ELVN | B | 2.05% | |
| JANX | C | 2.01% | |
| NUVB | B | 1.91% | |
| DAWN | C | 1.63% | |
| RVMD | C | 1.59% | |
| TSVT | D | 1.52% | |
| HCM | A | 1.46% | |
| ITOS | B | 1.44% | |
| YMAB | D | 1.44% | |
| XNCR | C | 1.42% | |
| BPMC | B | 1.41% | |
| MRK | B | 1.4% | |
| LYEL | C | 1.38% | |
| BCYC | D | 1.38% | |
| TYRA | C | 1.35% | |
| AURA | F | 1.34% | |
| IPHA | D | 1.32% | |
| ERAS | F | 1.31% | |
| SMMT | B | 1.29% | |
| MOR | B | 1.28% | |
| PGEN | F | 1.28% | |
| INBX | D | 1.28% | |
| SDGR | F | 1.28% | |
| MGNX | F | 1.27% | |
| FHTX | F | 1.27% | |
| BNTX | C | 1.27% | |
| EXEL | F | 1.27% | |
| SNDX | D | 1.27% | |
| RAPT | F | 1.27% | |
| GLUE | F | 1.27% | |
| VOR | F | 1.25% | |
| SWTX | D | 1.24% | |
| GMAB | F | 1.24% | |
| REGN | C | 1.24% | |
| NRIX | D | 1.22% | |
| STRO | D | 1.22% | |
| KURA | C | 1.21% | |
| IGMS | D | 1.21% | |
| KYMR | D | 1.2% | |
| IDYA | D | 1.2% | |
| IOVA | D | 1.15% | |
| RCUS | F | 1.11% | |
| BMY | F | 1.1% | |
| NUVL | D | 1.09% | |
| PRLD | D | 1.09% | |
| RLAY | F | 1.07% | |
| ZNTL | F | 1.05% | |
| KPTI | F | 1.05% | |
| DNA | F | 1.04% | |
| RXRX | F | 1.01% | |
| ACLX | F | 0.98% | |
| ACET | F | 0.97% | |
| REPL | F | 0.96% | |
| ARVN | F | 0.95% | |
| AUTL | F | 0.92% | |
| BMEA | F | 0.9% | |
| CRBU | F | 0.9% | |
| MRSN | F | 0.88% | |
| LEGN | F | 0.87% | |
| ALLO | F | 0.85% | |
| RPTX | F | 0.83% | |
| FATE | D | 0.74% | |
| GNLX | F | 0.69% | |
| IMRX | F | 0.69% |
CNCR Underweight 20 Positions Relative to FPXE
CNCR: Top Represented Industries & Keywords
FPXE: Top Represented Industries & Keywords
Compare ETFs
